NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: ChemImage Corporation

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

ChemImage Sensor Systems to Discuss Novel Methods for the Detection of Explosives at Prestigious Analytical Chemical and Spectroscopy Conference - Charles W. Gardner, Ph.D. PMP will give a technical presentation discussing the company's work on the detection of explosives and other threat materials using innovative hyperspectral imaging methods at Pittcon - ChemImage.com
ChemImage Sensor Systems to Discuss Novel Methods for the Detection of Explosives at Prestigious Analytical Chemical and Spectroscopy Conference

 

NewswireTODAY - /newswire/ - Pittsburgh, PA, United States, 2016/03/08 - Charles W. Gardner, Ph.D. PMP will give a technical presentation discussing the company's work on the detection of explosives and other threat materials using innovative hyperspectral imaging methods at Pittcon - ChemImage.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

ChemImage Sensor Systems (CISS) announced today that Director of Product Management, Charles W. Gardner, Ph.D. PMP, will give a technical presentation discussing the company's work on the detection of explosives and other threat materials using innovative hyperspectral imaging methods during the 2016 Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy (Pittcon) in Atlanta, Georgia.

Dr. Gardner's lecture entitled,"Novel Approaches to Standoff Hyperspectral Imaging Based Detection of Explosives and Other Threats" will be presented during the "Standoff Detection Methods for Security Applications" session on Wednesday, March 9, 2016 at 8:35am. His discussion will provide attendees with an overview of the project and the capabilities of the system's technology in the detection of improvised explosive devices through the use of portable hyperspectral imaging.

"It is a great opportunity for me to present the work we have completed to the spectroscopy community during Pittcon 2016 and have the opportunity for discussion and feedback on the project," said Gardner, who was also recently selected to be the President of Pittcon 2019.

The Pittsburgh Conference is a Pennsylvania not-for-profit educational corporation that is comprised of the Spectroscopy Society of Pittsburgh (SSP) and the Society for Analytical Chemists of Pittsburgh (SACP). Pittcon is the world's leading annual conference and exposition on laboratory science. Pittcon attracts more than 16,000 attendees from industry, academia and government from over 90 countries worldwide. Pittcon's roots started in Pittsburgh in 1950 and is managed by a committee of volunteers and a 11-person staff.

About ChemImage Sensor Systems
CISS develops innovative products that utilize patented imaging capabilities and leverage current in-the-field technologies to address the ever-changing landscape of chemical, biological and explosive (CBE) threats. CISS has developed a series of chemical imagiing sensors for point, proximity, remote and standoff detection and identification in both fixed site and on-the-move configurations, in order to protect military troops, security personnel and citizens.

ChemImage Sensor Systems is a subsidiary of ChemImage Corporation, a leader in chemical imaging technology and instrumentation.

About ChemImage
ChemImage Corporation (chemimage.com), a leader in hyperspectral and Raman chemical imaging technology provides innovative instrumentation, analysis software, contract services and expert consulting to government, industrial and academic organizations. The company's proprietary, state-of-the-art imaging technology has many applications, including defense, security, pharmaceuticals, forensics and biomedical diagnostic research, which can reveal critical chemical and biological information from a variety of material systems.

ChemImage's headquarters are located in Pittsburgh, PA, where it pioneers research and development, as well as providing engineering and manufacturing which develops innovative products for the global marketplace.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: ChemImage Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


ChemImage Sensor Systems to Discuss Novel Methods for the Detection of Explosives at Prestigious Analytical Chemical and Spectroscopy Conference

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Tifanie Tiberio - ChemImage.com 
412-241-7335 x269 tiberiot[.]chemimage.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any ChemImage Corporation securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From ChemImage Corporation / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Ono Pharma Announces an Exclusive License Agreement with Biohaven to Develop and Commercialize IgG Degraders in Japan, South Korea, Taiwan, and ASEAN
Ono Received Manufacturing and Marketing Approval in Japan for XCOPRI® Tablets for the Treatment of Patients with Partial-onset Seizures
Molecular Devices and STEMCELL Technologies Collaborate to Accelerate Adoption of Human-Relevant Organoid Models through Automation
ZAGENO Earns Frost & Sullivan’s 2026 North American Life Sciences E‑Commerce Company of the Year Recognition
SCHOTT Pharma, Takeda and Corplex Bring Closed-loop Recycling System for Pharmaceutical Vial Trays into Operations
Ono Pharma Enters into a Drug Discovery Partnership with Aitia in Neurological Diseases
STEMCELL Technologies Joins BLOODPAC to Advance Pre-Analytical Best Practices for Liquid Biopsy
OPDIVO® Intravenous Infusion Approved in Taiwan for the Treatment of Resectable Non-Small Cell Lung Cancer
Ono Pharma Enters into a Drug Discovery Partnership with Mediar Therapeutics to Create Novel Antibody Therapeutics for Fibro-inflammatory Diseases
OPDIVO® Intravenous Infusion Approved in South Korea for the Treatment of Resectable Non-Small Cell Lung Cancer
Ipsen Completes Acquisition of Memo Therapeutics AG, Adding First-in-class Asset to Ipsen’s Rare Disease Pipeline
SCHOTT Pharma and Nemera Deliver Verified Pen Injector Platform with Sterile Cartridge System
IQIRVO® Demonstrates Statistically Significant Improvement in ALP Normalization in Patients with PBC in Phase IIIb ELSPIRE Study
Dysport® is the First Botulinum Toxin to Achieve Positive Topline Phase III Results in Both Episodic and Chronic Migraine
STEMCELL Technologies and CCRM Partner to Expand Access to Matched GMP and RUO iPSC Lines for Cell Therapy Development

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit BizJobs.com





 
  ©2005-2026 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS | 
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)